drug repurposing

REPO-TRIAL

The EU H2020 project REPO-TRIAL aims at developing an **in silico** approach to optimise the efficacy and precision of drug repurposing trials. To this end we integrated heterogeneous data into a comprehensive interactome of disease-drug-gene interactions (a new diseasome).